Nov 17, 2025 • Motley Fool
SOMEWHAT-BULLISH
This Fund Sold $9 Million of Ligand Stock After an 84% Rally - What Investors Should Know
A high-conviction fund just trimmed one of its biggest winners-here's what long-term investors should make of the move.
Nov 10, 2025 • GlobeNewswire
SOMEWHAT-BULLISH
Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
NEW HOPE, Pa., Nov. 10, 2025 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, "Orchestra BioMed" or the "Company" ) , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced financial results for the ...
Nov 07, 2025 • GlobeNewswire
SOMEWHAT-BULLISH
Pelthos Therapeutics Acquires Xepi® ( ozenoxacin ) Cream, 1% and Announces $18 Million Private Convertible Notes Financing
DURHAM, N.C., Nov. 07, 2025 ( GLOBE NEWSWIRE ) -- Pelthos Therapeutics Inc. ( NYSE American: PTHS ) , a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs ( "Pelthos" ) , today announced it has acquired the U.S. commercialization rights ...
Nov 07, 2025 • Benzinga
SOMEWHAT-BULLISH
Pelthos Therapeutics Acquires Xepi® ( ozenoxacin ) Cream, 1% and Announces $18 Million Private Convertible Notes Financing - Ligand Pharmaceuticals ( NASDAQ:LGND ) , Pelthos Therapeutics ( AMEX:PTHS )
Acquisition adds complementary dermatology product to the Pelthos portfolio anchored by ZELSUVMI™ Xepi is a novel FDA-approved topical treatment for impetigo that addresses a critical unmet need in antibiotic-resistant skin infections caused by staph and strep infections, most commonly affecting ...
Nov 07, 2025 • Benzinga
NEUTRAL
EXCLUSIVE: Pelthos Secures Rights To Antimicrobial Drug, Raises $18 Million To Support Commercial Launch - Pelthos Therapeutics ( AMEX:PTHS )
Pelthos Therapeutics Inc. ( NYSE:PTHS ) on Friday acquired the U.S. commercialization rights to Xepi ( ozenoxacin ) Cream, 1%, from Biofrontera Inc. ( NASDAQ:BFRI ) and Ferrer Internacional S.A.
Nov 06, 2025 • Motley Fool
SOMEWHAT-BULLISH
Ligand ( LGND ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, Nov. 6, 2025, at 8:30 a.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading ...